# Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

> **NCT00038701** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **DRUG:** TNP-470

## Key facts

- **NCT ID:** NCT00038701
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-08
- **Primary completion:** 2004-05-11
- **Final completion:** 2004-05-11
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow accrual.
- **Last updated:** 2018-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038701, "Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00038701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*